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ABSTRACT
A reporter assay was developed to detect and quan-
tify nonsense codon suppression by chemically
aminoacylated tRNAs in mammalian cells. It is
based on the cellular expression of the enhanced
green ¯uorescent protein (EGFP) as a reporter for
the site-speci®c amino acid incorporation in its
sequence using an orthogonal suppressor tRNA
derived from Escherichia coli. Suppression of an
engineered amber codon at position 64 in the EGFP
run-off transcript could be achieved by the incorpor-
ation of a leucine via an in vitro aminoacylated sup-
pressor tRNA. Microinjection of de®ned amounts of
mutagenized EGFP mRNA and suppressor tRNA
into individual cells allowed us to accurately deter-
mine suppression ef®ciencies by measuring the
EGFP ¯uorescence intensity in individual cells
using laser-scanning confocal microscopy. Control
experiments showed the absence of natural sup-
pression or aminoacylation of the synthetic tRNA by
endogenous aminoacyl-tRNA synthetases. This
reporter assay opens the way for the optimization of
essential experimental parameters for expanding
the scope of the suppressor tRNA technology to
different cell types.
INTRODUCTION
The site-speci®c incorporation of unnatural amino acids into
proteins in living cells is of importance to analyze in vivo
protein structure and function as well as cellular processes
using amino acid analogs comprising probes which are photo-
activatable, ¯uorescent or chemically reactive (1±6). This
emerging technology relies on the suppression of nonsense
codon mutations by chemically acylated tRNAs and has been
originally developed as an in vitro method (7±12). Meanwhile,
several reports for its in vivo application in Xenopus oocytes
(4±6,13,14), Escherichia coli (15±18) and COS1 cells (19)
appeared in the literature. An expansion of this technology to
other cell lines would demand a reporter system permitting
the de®nition of optimal parameters for the site-speci®c
incorporation of amino acid analogs into proteins.
Here, suppressor tRNA technology was applied to Chinese
hamster ovary (CHO) cells which, like other mammalian cell
types, are generally more suitable for structural and functional
studies of human-derived proteins if speci®c post-translational
modi®cations are important. In addition, certain proteins such
as neuro-receptors are optimally expressed only in particular
cell lines. We focused on the enhanced green ¯uorescent
protein (EGFP) as a reporter to assess the ef®ciency of
nonsense codon suppression directly in living cells. An amber
stop codon mutation was site-speci®cally introduced in the
core position of the EGFP, removing an amino acid essential
for the formation of the ¯uorophore. The transfer of that
mutagenized in vitro transcript into CHO cells was followed
by the expression of an incomplete, non-¯uorescent protein.
After co-transfer with a cognate synthetic suppressor tRNA,
we could monitor the successful re-incorporation of the
missing amino acid by recovery of the EGFP ¯uorescence
signal, which could be quanti®ed by using laser-scanning
confocal microscopy on living cells.
Unlike other ¯uorescent reporters such as luciferase or
b-galactosidase, EGFP does not require the addition of
substrate or cofactors nor cell lysis or ®xation. Furthermore,
it is stable over a period of several days and, due to its strong
¯uorescence, allows an accurate and sensitive determination
of suppression ef®ciencies in individual cells. This strategy
could be used to ®nd proper conditions for an ef®cient
suppression in a number of different mammalian cell lines.
MATERIALS AND METHODS
Materials
Synthetic oligonucleotides were purchased at MWG-Biotech
AG (Ebersberg, Germany). Kits for plasmid and DNA-
fragment puri®cation were obtained from QIAGEN GmbH
(Hilden, Germany). Restriction endonucleases (BsaI, EcoRI
and NotI) were provided by New England Biolabs (MA,
USA). The MEGAscript kit for in vitro transcription and the
cap analog m7G(5¢)ppp(5¢)G were from Ambion (TX, USA).
Puri®ed rEGFP was purchased at Clontech (CA, USA).
Octadecyl rhodamine B (R18) and Alexa Fluor 546 C5
maleimide were obtained from Molecular Probes (OR, USA).
Other chemicals were purchased at Sigma-Aldrich (MO,
USA).
Transcription of reporter gene
The coding sequence of the EGFP (pEGFP-N1, Clontech) was
modi®ed by the addition of a T7 promoter site and a poly(A)
tail using PCR ampli®cation with synthetic oligonucleotides
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(Fig. 1). The resulting 814 bp fragment was ligated into the
pCR2.1 vector using the TA cloning kit (Invitrogen, CA,
USA) to obtain the plasmid pT7PEGFP.
The pT7PEGFPam64L is a mutated version of the
pT7PEGFP plasmid. The CTG codon at position 64 of the
EGFP coding sequence was mutated to a nonsense amber
(TAG) codon by site-directed mutagenesis using the
Quickchange kit (Stratagene, CA, USA). All plasmid con-
structs were controlled by restriction mapping and DNA
sequencing.
After linearization of the wild-type and mutated plasmids
by NotI, in vitro transcription was performed with T7 RNA
polymerase using the MEGAscript kit (Ambion). Capping of
mRNA was achieved during transcription by replacing 80% of
the GTP level with the cap analog m7G(5¢)ppp(5¢)G (Ambion).
After removing the DNA template by DNase I treatment, the
resulting mRNAs were puri®ed by successive phenol±
chloroform±isoamyl alcohol (25:24:1) and chloroform±
isoamyl alcohol (24:1) extractions, precipitation with an
equal volume of isopropanol for 1 h at ±20°C, followed by
centrifugation at 0°C/20 800 g for 15 min. The mRNA pellet
was dried and redissolved in sterile DEPC-treated H2O. The
integrity and size of the mRNAs were assayed by agarose gel
electrophoresis under denaturing conditions, and the concen-
tration was determined by measuring the optical density at
260 nm.
Transcription of suppressor tRNA gene
A 105 bp synthetic template fragment encoding the E.coli
suppressor tRNAAlaCUA was prepared by reannealing and
ligating two synthetic oligonucletides containing the tRNA
gene ¯anked by a T7 promoter (Fig. 2). This blunt-end DNA
fragment was cloned into pCR4 vector using the TOPO
cloning kit (Invitrogen), following the instructions of the
manufacturer. The resulting plasmid pEcoliAlaCUA was
checked by restriction mapping and sequencing.
Plasmid pEcoliAlaCUA was linearized by successive
restriction endonuclease digests with EcoRI and BsaI. After
agarose gel puri®cation this DNA fragment was used for the
Figure 1. Scheme of the cloning steps for the wild-type (pT7PEGFP) and mutant EGFP (pT7PEGFPam64L) encoding plasmids used for the in vitro transcrip-
tion. PCR ampli®cation with primers 1 and 2 was performed to add a T7 promoter to the 5¢ end and a poly(A) tail to the 3¢ end of the EGFP coding sequence.
Primers 3 and 4 were used for replacing the leucine 64 codon by TAG, and providing silent mutations for clonal selection. All nucleotide sequence
modi®cations are shown in bold letters.
Figure 2. Scheme for the in vitro synthesis of the suppressor tRNA from a
synthetic DNA template by T7 run-off transcription. Two synthetic comple-
mentary oligonucleotides encoding the E.coli-derived suppressor
tRNAAlaCUA were annealed and cloned into the pCR4 vector, leading to
pEcoliAlaCUA. T7 RNA polymerase run-off transcription was performed
on the puri®ed EcoRI and BsaI fragment giving rise to a 76mer suppressor
tRNA.
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run-off transcription with T7 RNA polymerase following the
protocol of the MegaScript kit (Ambion). After removing the
template DNA by DNase I treatment the tRNA was puri®ed
by following the protocol described above for mRNA. The
integrity and purity of the tRNA was assayed by polyacryl-
amide gel electrophoresis, and the concentration was
determined by measuring the optical density at 260 nm.
Deprotection of N-(4-pentenoyl)-S-leucyl-tRNA
Pentenoyl-protected aminoacylated tRNAAlaCUA was synthe-
sized at Cruachem Ltd (Glasgow, Scotland, UK). Ten
micrograms of lyophilized protected tRNA were resuspended
in 10 ml of H2O. Deprotection was accomplished by adding
2.5 ml of 25 mM I2 in 1:1 THF±H2O and incubating the
mixture for 10 min at 25°C. The leucyl-tRNA was precipitated
by successive additions of 1.25 ml of 3 M NaOAc pH 5.3
and 31.25 ml of cold ethanol. After centrifugation at 0°C/20
800 g for 15 min the pellet was washed once with 70% cold
ethanol, dried and dissolved in H2O to a ®nal concentration of
4 mg/ml.
Cell lines and cell culture
Adherent mammalian cells (CHO) were grown in Dulbecco's
modi®ed Eagle's medium (DMEM/F12; GIBCO BRL,
Rockville, USA). The medium was supplemented with 2.2%
fetal calf serum (GIBCO BRL). The cultures were split,
distributed in 35 mm Nunc dishes at a density of 50 000
cells/ml 1 day prior to injection, and kept at 37°C in a
humidi®ed atmosphere with 5% CO2.
Injections
Microinjections of CHO cells with mRNA and tRNA mixtures
diluted in sterile DEPC-treated H2O were performed using an
InjectMan controller and a Transjector 5246 system (both
from Eppendorf, Hamburg, Germany) mounted on an
Axiovert S100TV inverted microscope (Carl Zeiss AG,
Oberkochen, Germany). FemtotipsII capillaries (Eppendorf)
were used for all injections.
Laser-scanning confocal microscopy
Laser-scanning confocal microscopy was performed using a
Zeiss LSM510 (Carl Zeiss AG). Detection and distinction of
the ¯uorescence signals of EGFP (excitation 488 nm/emission
505±530 nm), Alexa546 and R18 (excitation 543 nm/emission
>560 nm) was achieved by appropriate ®lter sets using a
multitracking mode. Scanning speed and laser intensity were
adjusted to avoid photobleaching of the ¯uorophores.
RESULTS
The general scheme used for in vivo visualization of mis-
acylated tRNA suppression is presented in Figure 3A. The
suppression ef®ciency was determined by measuring the
appearance of EGFP ¯uorescence in living cells. The EGFP
coding sequence was mutated at position 64 by replacing the
CTG (leucine) codon with an amber stop codon in the core of
the reporter gene, giving rise to the EGFPam64L in vitro
transcript. A successful suppression by co-injection of this
mutated mRNA with a suppressor tRNA carrying the
`removed' amino acid would lead to the completion of the
EGFP translation. Twenty hours after co-injection of suppres-
sor leucyl-tRNA with EGFPam64L mRNA, we observed the
recovery of the EGFP ¯uorescence in CHO cells by laser-
scanning confocal microscopy (see Fig. 3B), whereas the
co-injection of the mutated mRNA together with the
non-aminoacylated tRNA did not lead to any detectable
¯uorescence within the cells (data not shown).
Because the injected volume may slightly vary between
cells, mostly depending on their intrinsic viscosity, it was
necessary to quantify this parameter in order to validate
further comparisons between different experiments. There-
fore, the injections of mRNA and tRNA were performed
together with a known concentration of Alexa546. This dye is
non-toxic for the cell and its excitation and emission
wavelengths are well distinguishable from those of EGFP.
Correlation between the ¯uorescence of the co-loaded dye
and the injected volume was obtained by measuring its
dilution in the cell and by calculating individual cell volumes.
Figure 3. In vivo suppression visualized by EGFP ¯uorescence recovery. (A) Schematic view of the assay for the amber suppressor tRNA function: co-injec-
tion of a mutated EGFP mRNA containing an amber codon at position 64 with an amber suppressor leucyl-tRNA. A successful suppression leads to complete
translation of the mRNA transcript, thus to the appearance of the EGFP molecule. (B) Laser-scanning confocal micrograph of CHO cells visualizing EGFP
¯uorescence 20 h after co-injection of the mutated EGFP-mRNA with the amber suppressor tRNA. Size bar is 10 mm.
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We ®rst elaborated a ¯uorescence intensity calibration curve
by measurements on droplets containing known concentra-
tions of the Alexa546 dye using laser-scanning confocal
microscopy. A linear relation between ¯uorescence intensity
and dye concentration was found. Fluorescence intensity
measurements of the co-injected Alexa546 dye on living cells
permitted the determination of the dye concentration within
the cells on the basis of this calibration curve.
The injection volume of the Alexa dye together with mRNA
and tRNA mixtures can then be determined by calculating the
cell volume. Therefore, we detached the adherent cells by
addition of 1 mM EDTA and incubation at 37°C for 10 min.
Under these conditions the cells became spherical. They were
then membrane-stained with R18 (5 mM/10 min incubation at
37°C) to measure their diameter by laser-scanning confocal
microscopy, leading to a volume of 1.2 6 0.1 pl (data not
shown). The number of EGFP molecules which were
expressed during in vivo translation in individual cells can
be estimated by comparison of cell-derived EGFP ¯uores-
cence intensities with EGFP ¯uorescence intensities measured
on droplets of known concentrations of puri®ed rEGFP.
To validate the precision of our injections and concentration
calibrations, we also co-injected variable volumes of a
solution containing 500 ng/ml rEGFP and 250 ng/ml
Alexa546 in CHO cells. As seen in Figure 4, there is a linear
correlation between injected volume, given by the Alexa546
¯uorescence signal, and the number of EGFP molecules per
cell.
On the basis of the presented control experiments we
performed all following measurements using concentrations
of 250 ng/ml Alexa546, 2 mg/ml mRNA and 2 mg/ml leucyl-
tRNAAlaCUA. These concentrations gave the best suppression
ef®ciencies: (i) permitting the highest number of RNA
molecules delivery without capillary blocking due to the
resulting high solution viscosity, and (ii) favoring the
suppression against competing endogenous termination
factors at an excess of 10:1 of tRNA:mRNA molecules.
The EGFP ¯uorescence resulting from in vivo suppression
was stable between 12 and 24 h post-injection. The injected
cells were easily identi®ed under the microscope via ¯uores-
cence of the co-injected dye. Thereby we could con®rm that
every injected cell turned green and could be re-identi®ed
even after 24 h incubation at 37°C. Using the EGFP and
Alexa546 ¯uorescence intensity calibration curves, we calcu-
lated the number of translated EGFP molecules by confocal
microscopy 20 h after microinjection. Because the variation
between injection volumes was 0.05 6 0.01 pl, we corrected
the number of translated EGFP molecules by normalization to
an average injection volume of 0.05 pl (Table 1). We obtained
suppression ef®ciencies of 15 6 3% by comparing EGFP
¯uorescence signals resulting from in vivo suppression with
¯uorescence signals derived from the injection of the identical
amounts of non-mutated EGFP mRNA.
The microinjection of a non-aminoacylated tRNA together
with the mutagenized reporter transcript did not produce any
detectable ¯uorescence at the EGFP emission wavelength of
510 nm in CHO cells when we used the identical parameters of
confocal microscopy (laser intensity, sensitivity of detection,
pinhole diameter, ®lter sets, etc.) as for measuring the EGFP
¯uorescence recovery upon nonsense codon suppression. If we
substantially increased the laser power for the excitation at
488 nm and the sensitivity of ¯uorescence signal detection
at 510 nm we could hardly detect unspeci®c cellular
auto¯uorescence, identical to that of non-injected control
cells.
DISCUSSION
A novel assay has been developed using EGFP as a reporter
for direct quanti®cation of termination codon suppression
ef®ciencies in living mammalian cells. We have shown by
¯uorescence recovery that an aminoacylated tRNA derived
from E.coli can suppress an amber mutation at codon 64 of the
EGFP mRNA by in vivo translation in CHO cells, whereas the
Figure 4. Correlation between injection volume and number of EGFP
molecules per cell by microinjection of variable volumes of a solution con-
taining 500 ng/ml rEGFP and 250 ng/ml Alexa546 in CHO cells. The
injected volume is calculated on the basis of the known cell volume (see
text for detailed description) and the ®nal concentration of Alexa546 dye
measured directly in the cell (based on a calibration curve established
before).
Table 1. Number of mRNA and tRNA molecules per cell directly calculated after microinjection by comparison of the co-injected Alexa dye with the
confocal calibration curve on droplets






EGFPam64L mRNA + tRNACUA 250 6 20 2500 6 200 ND
EGFPam64L mRNA + leucyl-tRNACUA 250 6 20 2500 6 200 270 6 30
EGFP mRNA 250 6 20 ± 1800 6 200
Expression of EGFP molecules per cell determined on 50 individual cells, 20 h after injection of RNA. The values are corrected for a standard injection
volume of 0.05 pl. Co-injections were all processed using concentrations of 2 mg/ml mRNA, 2 mg/ml tRNA and 250 ng/ml Alexa546. ND, not detectable.
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non-aminoacylated form of the same tRNA cannot. EGFP
¯uorescence intensities measured in individual cells by laser-
scanning confocal microscopy allowed us to quantify sup-
pression ef®ciencies. Kohrer et al. (19) have used a different
approach to insert amino acid analogs into the chlor-
amphenicol acetyltransferase (CAT) by importing a suppres-
sor Tyr-tRNA in COS1 cells using lipofection. These authors
measured CAT activities in cell extracts to determine average
levels of termination codon suppression ef®ciencies in cell
samples but not on individual cells.
The use of EGFP as a suppression reporter offers advan-
tages compared to other detection techniques such as those
based on luciferase, b-galactosidase or CAT. In contrast to
these destructive methods, EGFP suppression can be followed
in vivo in a single cell without further chemical or enzymatic
treatment, due to the suf®ciently high quantum yield of this
protein.
To improve the suppression-speci®c ¯uorescent signal, we
increased the signal-to-noise ratio by lowering the background
signal resulting from possible natural suppressor tRNAs. This
was ful®lled by choosing an amino acid in the protein
sequence that plays an important role for the ¯uorescence
properties of the EGFP. In consequence, a cell line which
comprises a natural suppressor tRNA aminoacylated with a
different amino acid would provide a background signal
reduced to an undetectable value. We selected the leucine at
position 64 for its importance in the ¯uorescence properties of
the EGFP, in particular because it greatly improves correct
protein folding (20,21). Furthermore, due to the fact that it is
neither a charged nor a polar amino acid, it is more quickly
accepted and processed by the ribosome, thus better compet-
ing with the undesirable effect of termination factors which
could prevent the completion of the full-length protein
(22±26).
To determine the contribution of the unnatural suppression
under investigation, the suppressor tRNA should also not be
recognized by any endogeneous aminoacyl-tRNA synthetases.
This natural aminoacylation of the suppressor tRNA can be
minimized by choosing a tRNA from another organism. In our
present study, the tRNA sequence was based on that of E.coli
tRNAAlaGGC (27) mutated to CUA at the anticodon site and
modi®ed by two other mutations: A38U improves amber
suppression ef®ciency (28±30) and C70U renders the non-
aminoacylated tRNA a poor substrate for E.coli alanyl-tRNA
synthetase (31). This tRNA sequence has been shown by
Karginov et al. (9) to have good suppression properties in
in vitro translation systems.
Our experiments to determine suppression ef®ciencies by
measuring EGFP ¯uorescence intensities in cells and to
estimate amounts of injected mRNA and tRNA molecules
were based on laser-scanning confocal microscopy measure-
ments. Microinjection of de®ned amounts of ¯uorescent dyes
in CHO cells demonstrated the suitability of this transfection
technique to incorporate, in a controlled way, quanti®able
molecule amounts, in contrast to saponin permeabilization
(32), electroporation (33) or lipofection (19) of mammalian
cells. Furthermore, unlike these other techniques, control of
the transfected amount does not depend on cell type or density,
allowing a more accurate comparison between different cell
types. Finally, microinjection requires only low amounts of
material, and prevents the RNA degradation that can take
place during delivery in other transfection techniques.
We were able to observe amber suppression of an amber
mutated EGFP mRNA using mis-acylated tRNA in CHO cells,
obtaining 15 6 3% of the ¯uorescence signal obtained by
injection of the same amount of non-mutated EGFP mRNA.
After estimation of the RNA molecules and EGFP protein
numbers, we obtained approximately one suppressed transla-
tion by mRNA (see Table 1). Referring to a typical injection
volume in CHO cells of 0.05 pl, the number of proteins
resulting from unnatural suppression was in the range of
270 000 6 30 000.
The general applicability of the presented EGFP-based
reporter assay will allow us to extend the suppressor tRNA
technique for many other cell types, and hence permit the
selection of suitable suppressor tRNAs for the site-directed
modi®cation of proteins. Of particular interest for applying
suppressor tRNA technology are investigations of selective
molecular interactions in live biological cells by ¯uorescence
techniques with high time, spatial and single molecule
resolution, to elucidate the complex cellular biochemical
networks (34±36).
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